Next-generation NovaSure® device for endometrial ablation: assessing ease-of-use among physicians
Whitney Pollock1, William Jamieson2
1The Gynecology Center, Pottsville, PA, USA; 2University of Cincinnati, Christ Hospital, Cincinnati, OH, USA
Objective: To compare physician assessment of the next-generation NovaSure® device to the original NovaSure device.
Design: Prospective open-label, unblinded survey utilizing Likert scales.
Setting: Community-based obstetrician and gynecology practices.
Patients: There were 270 evaluations completed by 168 physicians for women undergoing endometrial ablation with the next-generation NovaSure device compared to the previous model.
Interventions: Physician survey across multiple community-based obstetrician and gynecology practices.
Measurements and main results: In general, 53.7% of women had a normal uterus, with an average cavity length of 5.3 cm ± 0.9 cm, and 44.7% of women had a normal cervix. Overall, 98.7% of physicians agreed or strongly agreed that they were satisfied with the performance of the next-generation NovaSure device compared with the previous device. Additionally, 89% of physicians rated the next-generation NovaSure device as superior to the previous device. The best rated features were the SureFit™ Cervical Seal, Smooth Access™ Tips, and the thumb-pusher. No adverse events were reported in this study.
Conclusion: Community-based physicians rated the next-generation NovaSure device as superior to the previous model in a general population of women.
Keywords: NovaSure, menorrhagia, endometrial ablation, hysterectomy
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]